🇺🇸 FDA

Intelligence Platform

Patents

Browse 88 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11344577

Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA

The Board of Regents of the University of Texas System · Granted Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11161908

BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11154573

Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-ce

The Regents of the University of California · Granted Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11117945

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. · Granted Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11078252

T-cell receptor

University College Cardiff Consultants Limited · Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11008314

Compounds and methods for modulating interleukin-2-inducible t-cell kinase

Corvus Pharmaceuticals, Inc. · Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10993959

Methods and compositions for increasing the suppressive function of regulatory T-cells (Tr

Regents of the University of Minnesota · Granted Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10927158

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. · Granted Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10874727

Inducible regulatory t-cell generation for hematopoietic transplants

Regents of the University of Minnesota · Granted Tue Dec 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633451

Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine

Ludwig-Maximilians-Universitat Munchen · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10633445

T-cell receptor (TCR)-binding antibodies and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10562975

CD6 antibody for treatment of T-cell mediated diseases or disorders

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10407484

Compositions and methods for modulating T-cell mediated immune response

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10391126

CAR+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA

The Board of Regents of the University of Texas System · Granted Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9649339

LAT adapter molecule for enhanced T-cell signaling and method of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9645147

Recombinant polypeptide construct comprising Plasmodium falciparum circumsporozoite protei

United States of America as represented by the Secretary of the Air Force · Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9629877

Human application of engineered chimeric antigen receptor (CAR) T-cells

The Board of Regents of the University of Texas System · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9572873

Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral

The Regents of the University of California · Granted Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9512401

B and T lymphocyte attenuator marker for use in adoptive T-cell therapy

The Board of Regents of the University of Texas System · Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9481866

Methods of producing T cell populations enriched for stable regulatory T-cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9301947

Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

The Regents of the University of California · Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9243051

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

United States Government as represented by the Department of Veterans Affairs · Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9228172

Inducible regulatory T-cell generation for hematopoietic transplants

Regents of the University of Minnesota · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9084762

T-cell immunogens derived from anti-viral proteins and methods of using same

The Regents of the University of California · Granted Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted